Lifting the country’s 43-year moratorium would be a major human rights setback.

On International Women’s Day 2019, dozens of organisations joined forces to call out the disproportionate impact of the war on drugs on women and gender non-conforming people.

The webinar will shed light on the key controversies that are likely to structure the debates, discuss tabled resolutions and opportunities for engagement, and showcase the experience of IDPC network members in navigating and leveraging this forum for political advocacy.

A year that has seen the organisation learn and grow, as well as become equipped to understand how the drug policy agenda can continue to be informed in 2019.

The article entails a four step process as to how people can actively change drug policy within their country.

EHRA present within this report, a plan to strategically integrate harm reduction programmes into national health and social systems across Eastern Europe and Central Asia.

EHRA present within this report, a plan to strategically integrate harm reduction programmes into national health and social systems across Eastern Europe and Central Asia.

This advocacy note outlines key issues for consideration as member states reflect on what has been achieved since 2009, and the implications for the next phase of the international drug policy regime.

EHRA provides their annual report, highlighting milestones and progress made on drug policy and harm reduction in both Europe and Asia.

The CSTF has been re-launched to support civil society participation in the upcoming Ministerial Segment of the 62nd Session of the CND.